Clinical Ambitions and Retail Realities: Analysis of Best Buy's Acquisition and Divestiture of Current Health

Nelson Advisors
7 hours ago
11 min read

In late 2021, amid a broader pandemic-fuelled surge in remote healthcare and virtual care solutions, electronics retailer Best Buy sought to expand its healthcare footprint under its "Best Buy Health" banner. The cornerstone of this healthcare expansion was the acquisition of Current Health, an at-home care and remote patient monitoring platform, for approximately $400 Million.

At the time, the transaction was positioned as a synergistic masterstroke: Best Buy would combine Current Health's FDA-cleared wearable sensors and clinical platform with the retail giant's massive logistics infrastructure and the in-home tech support of its Geek Squad division.

However, by June 2025, the retail giant shifted its strategy, divesting Current Health back to its original co-founder, Christopher McGhee, for an undisclosed sum, laying off healthcare staff and significantly scaling back its clinical ambitions.

This strategic retreat highlights the profound challenges of merging retail business models with the highly regulated, clinically complex and financially volatile American healthcare sector.

The Evolution of Best Buy Health and the Current Health Acquisition

Best Buy’s foray into healthcare began long before its acquisition of Current Health. The company initialed its healthcare strategy in 2018 with the $800 Million purchase of GreatCall Inc., a developer of cellular devices and emergency response services designed specifically for senior citizens. In 2019, the retailer deepened this senior-focused portfolio by acquiring Critical Signal Technologies, a remote-monitoring provider specialising in active aging and medical alert systems.

With the onset of the COVID-19 pandemic, the demand for virtual care and remote monitoring skyrocketed. This shift prompted Best Buy to expand from passive senior monitoring into acute, clinical-grade "hospital-at-home" models. In October 2021, Best Buy agreed to acquire Current Health, which was founded in 2014 by Christopher McGhee after he witnessed his grandmother struggle to manage chronic obstructive pulmonary disease, dementia and congestive heart failure from home.

Current Health’s enterprise platform combined proprietary, continuous-monitoring wearable sensors with integrated telehealth, patient engagement applications and deep integrations with electronic health record platforms such as Epic. The strategic timeline below outlines the rapid escalation of Best Buy’s healthcare capital deployment and its subsequent, multi-stage financial retrenchment.

Strategic Phase	Date / Fiscal Period	Corporate Event / Transaction	Financial Impact	Strategic Target
Market Entry	August 2018	Acquisition of GreatCall Inc.	$800 Million cash outlay	Passive senior safety and emergency cellular service.
Portfolio Deepening	2019	Acquisition of Critical Signal Technologies	Undisclosed	Expansion into remote senior monitoring and alerts.
Clinical Expansion	Late 2021	Acquisition of Current Health	$400 Million cash outlay	Enterprise hospital-at-home and oncology-at-home models.
Initial Retrenchment	Q4 2024 / Q4 FY25	Best Buy Health Goodwill Impairment	$475 Million non-cash charge	First downward revision of long-term healthcare projections.
Structural Clean-cut	May 2025	Restructuring and 161 Layoffs	$109 Million restructuring charge	Termination of underperforming hospital partnerships.
Divestiture	June 2025	Sale of Current Health to Founder	Undisclosed	Exit from enterprise care-at-home clinical platforms.
Final Write-down	Q3 Fiscal 2026 (Nov 2025)	Asset and Goodwill Impairment	$192 Million non-cash charge	Total write-off of residual hospital-at-home clinical assets.

The Synergistic Thesis: Repurposing the Geek Squad for Clinical Care

The core operational thesis of the Current Health acquisition was to resolve the "last mile" of clinical care delivery. While major hospital networks recognized the cost benefits of shifting acute care to patients' homes, clinicians lacked the supply chain and technical capabilities to manage thousands of remote medical devices.

Best Buy intended to position its Geek Squad division. a technical workforce of over 100,000 agents, as the physical infrastructure layer for remote patient monitoring.

Under this partnership model, Geek Squad agents underwent specialized health technology training, distinguishing their roles from standard home theater or appliance installations. When a health system such as Geisinger or Atrium Health enrolled a patient in a hospital-at-home program, Geek Squad agents were dispatched to the home to deliver, install, and activate the medical equipment. These agents bridged the digital divide by configuring cellular hotspots for patients with unstable internet, providing multilingual tutorials, and troubleshooting hardware. Upon patient discharge, the agents collected, sanitised, and returned the devices to the clinical inventory.

The early clinical and operational pilots of this integrated model yielded strong preliminary data across several major health systems, as outlined below.

Partner Health System	Program Focus	Technology Integrated	Documented Clinical & Operational Outcomes
Geisinger Health	ConnectedCare365 chronic disease management	Blood pressure cuffs, pulse oximeters, weight scales, glucose meters	Patient technology activation times were cut in half; significant improvements in care plan compliance and patient experience.
Baptist Health	Congestive heart failure (CHF) remote triage	Continuous continuous-monitoring wearables and clinical dashboard	Achieved an 8% survival rate among CHF patients at 90 days; established automated alarms triaged by a 24/7 Clinical Command Center.
OSF HealthCare	Post-discharge monitoring pathways	Bluetooth-enabled home devices and patient mobile apps	Documented a 2% reduction in hospital readmission rates.
Wrightington, Wigan & Leigh NHS Trust	Acute home-recovery pathways	Continuous vitals monitoring and clinical dashboards	Saved a total of 450 acute care hospital bed days.

Despite these localised operational successes, the underlying financial and structural mechanics of the partnership could not sustain the cost of maintaining this physical-clinical hybrid model at a national, enterprise level.

Operational and Regulatory Friction: The "HIPAA Hole" and Service Overhead

As Best Buy integrated Current Health, the company encountered operational and regulatory friction points that are unique to clinical medicine.

First, the overhead of clinical operations proved far more capital-intensive than a traditional retail business. Digital health pioneers noted that pure technology plays do not work in isolation within healthcare.

Current Health had to manage clinical command centres staffed by registered nurses 24/7, coordinate complex, sterile device logistics, and oversee compliance and drug adherence programs. This services-heavy model eroded the high operating margins typical of technology companies, turning Current Health into an expensive, labor-intensive asset.

Second, the deployment of retail personnel into clinical settings introduced legal risks under the Health Insurance Portability and Accountability Act (HIPAA). Healthcare experts and telemedicine pioneers, including Teladoc founder Michael Gorton, warned of a potential "HIPAA hole" created by sending retail workers into private homes to configure medical tech. While standard consumer electronics are simple to install, configuring a clinical remote patient monitoring device to transfer continuous physiological data directly to an electronic health record demands rigorous compliance.

The industry struggled with split-liability concerns. Hardware installers might claim their responsibility ended at setup, device vendors blamed the network conduits, and hospitals held liability only once data reached their servers. Under the law, if a service provider creates, receives, or maintains Protected Health Information (PHI) on behalf of a clinical entity, they must enter into a formal Business Associate Agreement (BAA) and implement strict data firewalls.

The training, auditing, and legal infrastructure required to protect Geek Squad agents from accidental HIPAA violations added compliance costs and slowed Best Buy's ability to quickly scale the service across new geographic regions.

The Reimbursement Trap and Regulatory Instability

The primary obstacle to scaling Best Buy's clinical home-care division was the instability of the federal reimbursement landscape. The rapid adoption of hospital-at-home models was driven by the CMS Acute Hospital Care At Home waiver program, launched during the pandemic to relieve hospital capacity strains.

This waiver allowed approved health systems to receive standard inpatient Medicare reimbursement rates for care delivered in patients' homes.

However, the federal government failed to establish a permanent legislative framework for these services, choosing instead to extend the waivers in short, unpredictable intervals. While legislative bodies introduced measures such as the Preserving Telehealth, Hospital, and Ambulance Access Act and the Hospital Inpatient Services Modernisation Act to propose five-year extensions, the lack of a permanent law paralyzed hospital capital commitments.

Hospitals were unwilling to invest millions of dollars to restructure their clinical workflows, purchase equipment, and integrate enterprise monitoring software like Current Health when the underlying reimbursement pathway could expire in a matter of months. This regulatory bottleneck slowed Current Health’s client acquisition rate, making it impossible for Best Buy to generate the transaction volumes required to cover its massive overhead.

By the end of 2025, the clinical division faced further pressure from severe contractions in the healthcare payer market.Sweeping policy proposals aimed at freezing provider taxes and cutting Medicaid spending, combined with rising costs in the Medicare Advantage market, forced major commercial insurers to scale back their strategies and cut adjacent social services. This downward trend in Medicaid and Medicare Advantage funding directly impacted the budgets of Best Buy's health system clients, resulting in a sudden shift in the division’s customer base. These combined pressures forced Best Buy to make downward revisions to its long-term projections, triggering a sequence of asset impairments.

The Broader Retail Retreat: A Comparative Market Analysis

Best Buy’s strategic rollback was not an isolated event; it occurred during a broader retrenchment of retail giants attempting to disrupt the healthcare industry. Throughout the pandemic, companies like Amazon, Walmart, and Walgreens invested billions of dollars to capture market share in clinical primary care and remote health. By 2024 and 2025, these companies encountered the same structural barriers: rising operating costs, low reimbursement rates, and a lack of established clinical equity.

Retail Corporation	Primary Healthcare Strategy	Peak Financial Investment	Execution Period	Retrenchment / Exit Actions	Primary Failure Drivers
Best Buy	At-home clinical remote patient monitoring and hospital-at-home integrations.	$400 Million acquisition of Current Health.	2021–2025.	Divested Current Health in June 2025; wrote down $667M in healthcare assets.	CMS waiver uncertainty, clinical services overhead, and Medicare Advantage pressures.
Walmart	Co-located primary care clinics offering clinical, dental, and optical services.	51 multi-service health centers across 5 states.	2019–2024.	Shuttered all 51 physical health centers and terminated its virtual care platform.	Low cash-pay volume, rising clinic labor expenses, and low Medicare/Medicaid reimbursement rates.
Walgreens	Value-based primary care clinics co-located with pharmacies via VillageMD.	$6.2 Billion majority stake (63%) in VillageMD.	2020–2025.	Wrote down $5.8 Billion in goodwill; closed 160 underperforming clinics.	Slow patient panel growth, poor multi-specialty productivity, and Medicare reimbursement cuts.
Amazon	Amazon Care virtual primary care and in-home nurse visits.	Undisclosed development costs.	2019–2022.	Shut down Amazon Care; pivoted to acquiring One Medical for $3.9 Billion.	Inability to secure enterprise corporate contracts and lack of physical network.

The shared failure of these diverse retail strategies underscores a fundamental market truth: consumer retail models are optimised for transactional, high-volume, low-margin operations, whereas clinical healthcare requires long-term, relationship-based, highly regulated coordination. Healthcare analysts note that these retail initiatives often contributed to rising healthcare costs by introducing disjointed care.

Patients utilising retail-based clinics frequently experienced duplicate testing and fragmented communication, which created systemic inefficiencies and alienated traditional health systems. Ultimately, these companies failed because they lacked "healthcare equity"—the deep-rooted clinical credibility and trust that traditional providers have spent decades building with patients and payers.

The Exit, Restructuring and Strategic Pivot

Best Buy's healthcare retrenchment was executed in a series of strategic and financial steps. The first major sign of financial distress appeared in the fourth quarter of 2024, when Best Buy recorded a pre-tax, non-cash goodwill impairment charge of $475 million against its Best Buy Health division.

This disclosure triggered a nearly 16% single-day stock drop on March 4th, forcing the company's leadership to restructure the healthcare segment.

In May 2025, Best Buy initiated a restructuring program that cost $109 million, which was primarily used to wind down underperforming hospital-at-home partnerships and lay off 161 employees within the health division. On June 24, 2025, Christopher McGhee announced that he had reacquired Current Health from Best Buy to run it as an independent, private startup. Key members of the original founding team, including co-founder Stewart Whiting, returned to lead the company, with McGhee reiterating his long-term mission to build the business outside the constraints of public retail earnings cycles. Best Buy committed to supporting the transition of existing patients over a period of several months.

The final separation occurred in the third quarter of fiscal 2026, when Best Buy recorded an additional $192 million pre-tax, non-cash asset impairment charge.

This final accounting loss was triggered by a complete change in Best Buy Health's customer base, as the company ended its remaining hospital-at-home relationships with healthcare systems.

While Best Buy has exited the clinical enterprise space, the company has not abandoned healthcare entirely. Instead, the retailer has narrowed its focus, pivoting back to its core consumer-facing retail strengths.

The active aging segment, which includes Lively senior cellular phones, medical alert wearables, and personal emergency response systems, remains a highly viable and profitable model for the company. By refocusing on senior consumer technology, Best Buy can leverage its existing retail stores, e-commerce platforms, and standard supply chain without the burden of clinical compliance, nursing operations, and medical billing.

Strategic Lessons and Takeaways

The rise and fall of Best Buy’s clinical healthcare experiment offers critical strategic lessons for corporate strategy at the intersection of retail, technology, and clinical medicine.

Healthcare is Not a Transactional Consumer Good

Retail corporations operate on transactional business models optimised for high-volume inventory turnover, customer convenience, and price transparency. Clinical healthcare, however, is a relationship-based service governed by third-party reimbursement, clinical protocols, and long-term care management. Assuming that retail expertise in consumer logistics can seamlessly transition into managing acute patient care under-estimates the complexity of clinical delivery.

Corporate strategists must recognise that medical technology is only an enabler; it cannot replace the clinical and systemic infrastructure required to treat sick patients.

The Perils of Aligning Capital to Temporary Regulatory Frameworks

Best Buy’s massive investment in Current Health was catalysed by temporary CMS waivers designed to expand hospital capacity during a global public health crisis. Investing hundreds of millions of dollars based on temporary emergency waivers exposes a corporation to severe policy risk.

When Congress and CMS failed to establish a permanent reimbursement pathway for hospital-at-home care, the enterprise market stalled.

Corporate entities should avoid committing significant capital to clinical markets until permanent, predictable reimbursement pathways are established by federal and commercial payers.

Pure Technology Plays Lack Viability in Complex Clinical Settings

The belief that software-as-a-service (SaaS) platforms can operate in healthcare with the same high margins and low overhead seen in other sectors is a common strategic error. Managing acute, complex care at home requires heavy human support services, including 24/7 nursing triage, device sanitisation, compliance monitoring, and patient outreach.

These labour-intensive operations erode typical technology margins. Companies entering this space must prepare for lower-margin, services-heavy operations rather than assuming technology alone can scale clinical models.

Brand Equity Does Not Equal Clinical Trust

Retailers often assume that their strong consumer brand awareness can easily translate into clinical credibility. However, patients and healthcare providers do not view a consumer electronics retailer as a trusted source for medical treatment.

Deploying retail personnel into clinical settings introduces not only operational risks, such as HIPAA data exposure, but also strategic pushback from health systems protective of their patient relationships.

Building true "healthcare equity" requires long-term clinical collaboration, a deep understanding of patient workflows, and alignment with traditional medical providers. Without this foundation, consumer brand giants will continue to find clinical markets highly resistant to disruption.

Nelson Advisors > European MedTech and HealthTech Investment Banking

Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. www.nelsonadvisors.co.uk

Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital

Nelson Advisors publish Europe’s leading HealthTech and MedTech M&A Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb

Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk

#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech